Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemot (Q42947144)
Jump to navigation
Jump to search
scientific article published on May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemot |
scientific article published on May 2009 |
Statements
1 reference
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemot (English)
1 reference
Hagop Kantarjian
1 reference
Stefan Faderl
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Sherry Pierce
1 reference
Ravin Garg
1 reference
Deborah Thomas
1 reference
Denise Lovshe
1 reference
1 May 2009
1 reference
1 reference
115
1 reference
10
1 reference
2147-2154
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference